Skip to main content
SpringerLink
Log in

CQ53. Is Chemotherapy for Advanced Thyroid Carcinoma Effective?

  • Chapter
  • First Online:
Treatment of Thyroid Tumor

  • 1326 Accesses

Abstract

The standard therapy for differentiated thyroid carcinoma is surgery and RAI therapy is postoperatively considered for patients with distant metastasis. Pathological lesions generally develop slowly, even when RAI therapy is not effective. In contrast, although the number is very small, there are patients with progressive pathological lesions that are difficult to control. This CQ examines the effectiveness of chemotherapy for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Matuszczyk A, Petersenn S, Bockisch A et al (2008) Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium. Horm Metab Res 40:210–213 (RS)

    Article  PubMed  CAS  Google Scholar 

  2. Droz JP, Schlumberger M, Rougier P et al (1990) Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy. Tumori 76:480–483 (RS)

    PubMed  CAS  Google Scholar 

  3. Shimaoka K, Schoenfeld DA, DeWys WD et al (1985) A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56:2155–2160 (RCT)

    Article  PubMed  CAS  Google Scholar 

  4. Argiris A, Agarwala SS, Karamouzis MV et al (2008) A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer. Invest New Drugs 26:183–188 (RS)

    Article  PubMed  CAS  Google Scholar 

  5. Leaf AN, Wolf BC, Kirkwood JM et al (2000) Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385). Med Oncol 17:47–51 (PS)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgery, Tokyo Medical University, Ibaraki Medical Center, 3-20-1 Chuo, Amimachi, Inashikigun, Ibaraki, 300-0395, Japan

    Minoru Fujimori

  2. Department of Breast and Endocrine Surgery, Clinical Science, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

    Hisato Hara

  3. Department of Thoracic and Thyroid Surgery, Tokyo Medical University, Tokyo, Japan

    Hidemitsu Tsutsui

Authors
  1. Minoru Fujimori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisato Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hidemitsu Tsutsui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minoru Fujimori .

Editor information

Editors and Affiliations

  1. Ito Hospital, 4-3-6 Jinguumae, Shibuya-ku, Tokyo, 150-8308, Japan

    Hiroshi Takami

  2. , Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe, 650-0011, Japan

    Yasuhiro Ito

  3. Noguchi Thyroid Clinic and Hospital Foun, 6-33 Noguchinaka-machi, Beppu, 874-0932, Japan

    Hitoshi Noguchi

  4. , Department of Breast and Endocrine Surge, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan

    Akira Yoshida

  5. , Department of Endocrine Surgery, Tokyo Women's Medical University, 8-1 Kawada- cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Takahiro Okamoto

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Japan

About this chapter

Cite this chapter

Fujimori, M., Hara, H., Tsutsui, H. (2013). CQ53. Is Chemotherapy for Advanced Thyroid Carcinoma Effective?. In: Takami, H., Ito, Y., Noguchi, H., Yoshida, A., Okamoto, T. (eds) Treatment of Thyroid Tumor. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54049-6_74

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54049-6_74

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54048-9

  • Online ISBN: 978-4-431-54049-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation